Role of EBERs in the Pathogenesis of EBV Infection

Advances in Cancer Research

Volumn 107, Issue , 2010, Pages 119-136

  Iwakiri, Dai ^a   Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN BARR VIRUS ENCODED RNA 2; EPSTEIN-BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 2; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3; VIRUS RNA;

BURKITT LYMPHOMA; CELL TRANSFORMATION; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; REVIEW; VIROLOGY;

BURKITT LYMPHOMA; CELL TRANSFORMATION, NEOPLASTIC; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMUNITY, INNATE; RNA, VIRAL; TOLL-LIKE RECEPTOR 3;

EID: 77951646634     PISSN: 0065230X     EISSN: 21625557     Source Type: Book Series    
DOI: 10.1016/S0065-230X(10)07004-1     Document Type: Chapter

References (75)

1. Akira, S., Takeda, K., Toll-like receptor signaling. Nat. Rev. Immunol. 4 (2004), 499–511.
2. Akusjärvi, G., Mathews, M.B., Andersson, P., Vennström, B., Pettersson, U., Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc. Natl. Acad. Sci. USA 77 (1980), 2424–2428.
3. Alexopoulou, L., Holt, A.C., Medzhitov, R., Flavell, R.A., Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001), 732–738.
4. Arrand, J.R., Young, L.S., Tugwood, J.D., Two families of sequences in the small RNA-encoding region of Epstein–Barr virus (EBV) correlate with EBV types A and B. J. Virol. 63 (1989), 983–986.
5. Bhat, R.A., Thimmappaya, B., Two small RNAs encoded by Epstein–Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc. Natl. Acad. Sci. USA 80 (1983), 4789–4793.
6. Bonnet, M., Guinebretiere, J.M., Kremmer, E., Grunewald, V., Benhamou, E., Contesso, G., Joab, I., Detection of Epstein–Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 91 (1999), 1376–1381.
7. Chang, K.L., Chen, Y.Y., Shibata, D., Weiss, L.M., Description of an in situ hybridization methodology for detection of Epstein–Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol./Pahol. 1 (1992), 246–255.
8. Chodosh, J., Holder, V.P., Gan, Y.J., Belgaumi, A., Sample, J., Sixbey, J.W., Eradication of latent Epstein–Barr virus by hydroxyurea alters the growth-transformed cell phenotype. J. Infect. Dis. 177 (1998), 1194–1201.
9. Clarke, P.A., Sharp, N.A., Clemens, M.J., Translational control by the Epstein–Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates. Eur. J. Biochem. 193 (1990), 635–641.
10. Clarke, P.A., Schwemmle, M., Schickinger, J., Hilse, K., Clemens, M.J., Binding of Epstein–Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res. 25:19 (1991), 243–248.
11. Clarke, P.A., Sharp, N.A., Clemens, M.J., Expression of genes for the Epstein–Barr virus small RNAs EBER-1 and EBER-2 in Daudi Burkitt's lymphoma cells: Effects of interferon treatment. J. Gen. Virol. 73 (1992), 3169–3175.
12. Dobbelstein, M., Shenk, T., In vitro selection of RNA ligands for the ribosomal L22 protein associated with Epstein–Barr virus-expressed RNA by using randomized and cDNA-derived RNA libraries. J. Virol. 69 (1995), 8027–8034.
13. Elia, A., Vyas, J., Laing, K.G., Clemens, M.J., Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein–Barr virus small RNA EBER-1. Eur. J. Biochem. 27 (2004), 1895–1905.
14. Fok, V., Friend, K., Steitz, J.A., Epstein–Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nuclecytoplasmic shuttling. J. Cell Biol. 173 (2006), 319–325.
15. Fok, V., Mitton-Fry, R.M., Grech, A., Steitz, J.A., Multiple domains of EBER 1, an Epstein–Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 12 (2006), 872–882.
16. Gilligan, K., Rajadurai, P., Resnick, L., Raab-Traub, N., Epstein–Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA 87 (1990), 8790–8794.
17. Greifenegger, N., Jäger, M., Kunz-Schughart, L.A., Wolf, H., Schwarzmann, F., Epstein–Barr virus small RNA (EBER) genes: Differential regulation during lytic viral replication. J. Virol. 72 (1998), 9323–9328.
18. Howe, J.G., Steitz, J.A., Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc. Natl. Acad. Sci. USA. 83 (1986), 9006–9010.
19. Howe, J.G., Shu, M.D., Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein–Barr virus-encoded EBER RNAs. J. Virol. 62 (1988), 2790–2798.
20. Howe, J.G., Shu, M.D., Epstein–Barr virus small RNA (EBER) genes: Unique transcription units that combine RNA polymerase II and III promoter elements. Cell 57 (1989), 825–834.
21. Iwakiri, D., Eizuru, Y., Tokunaga, M., Takada, K., Autocrine growth of Epstein–Barr virus-positive gastric carcinoma cells mediated by an Epstein–Barr virus-encoded small RNA. Cancer Res. 63 (2003), 7062–7067.
22. Iwakiri, D., Sheen, T.S., Chen, J.Y., Huang, D.P., Takada, K., Epstein–Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24 (2005), 1767–1773.
23. Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Fujieda, M., Kawa, K., Takada, K., Epstein–Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J. Exp. Med. 206 (2009), 2091–2099.
24. Kang, D.-C., Gopalkrishnan, R.V., Wu, Q., Jankowsky, E., Pyle, A.M., Fisher, P.B., mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 99 (2002), 637–642.
25. Kasahara, Y., Yachie, A., Takei, K., Kanegane, C., Okada, K., Ohta, K., Seki, H., Igarashi, N., Maruhashi, K., Katayama, K., Katoh, E., Terao, G., et al. Differential cellular targets of Epstein–Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 98 (2001), 1882–1888.
26. Katze, M.G., Wambach, M., Wong, M.L., Garfinkel, M., Meurs, E., Chong, K., Williams, B.R., Hovanessian, A.G., Barber, G.N., Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68, 000-Mr protein kinase in a cell-free system. Mol. Cell. Biol. 11 (1991), 5497–5505.
27. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J., Takeuchi, O., Akira, S., IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 11 (2005), 1074–1076.
28. Kikuta, H., Sakiyama, Y., Matsumoto, S., Oh-Ishi, T., Nakano, T., Nagashima, T., Oka, T., Hironaka, T., Hirai, K., Fatal Epstein–Barr virus-associated hemophagocytic syndrome. Blood 82 (1993), 3259–3264.
29. Kitagawa, N., Goto, M., Kurozumi, K., Maruo, S., Fukayama, N.T., Yasukaswa, M., Hino, K., Suzuki, T., Todo, S., Takada, K., Epstein–Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J. 19 (2000), 6742–6750.
30. Komano, J., Sugiura, M., Takada, K., Epstein–Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J. Virol. 72 (1998), 9150–9156.
31. Komano, J., Maruo, S., Kurozumi, K., Oda, T., Takada, K., Oncogenic role of Epstein–Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J. Virol. 73 (1999), 9827–9831.
32. Lerner, M.R., Andrews, N.C., Miller, G., Steitz, J.A., Two small RNAs encoded by Epstein–Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 78 (1981), 805–809.
33. Liu, P., Tarlé, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano, M.J., Collins, F.S., Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261 (1993), 1041–1044.
34. Maruo, S., Nanbo, A., Takada, K., Replacement of the Epstein–Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells. J. Virol. 75 (2001), 9977–9982.
35. Mckenna, S.A., Lindhout, D.A., Shimoike, T., Aitken, C.E., Puglisis, J.D., Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR. J. Mol. Biol. 372 (2007), 103–113.
36. Meurs, E., Chong, K., Galabru, J., Thomas, N.S., Kerr, I.M., Williams, B.R., Hovanessian, A.G., Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62 (1990), 379–390.
37. Meylan, E., Tschopp, J., Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses. Mol. Cell 22 (2006), 561–569.
38. Mizugaki, Y., Sugawara, Y., Shinozaki, F., Takada, K., Detection of Epstein–Barr virus in oral papilloma. Jpn J. Cancer Res. 89 (1998), 604–607.
39. Nanbo, A., Inoue, K., Adachi-Takasawa, K., Takada, K., Epstein–Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J. 21 (2002), 954–965.
40. Nanbo, A., Yoshiyama, H., Takada, K., Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. J. Virol 79 (2005), 12280–12285.
41. Nucifora, G., Begy, C.R., Erickson, P., Drabkin, H.A., Rowley, J.D., The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein–Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA 90 (1993), 7784–7788.
42. Rickinson, A.B., Kieff, E., Epstein–Barr virus. Fields, B.N., Knipe, D.M., Hoeley, P.M., (eds.) Fields Virology, 2002, Lippincott-Raven Publishers, Philadelphia, PA, 2575–2627.
43. Rooney, C., Howe, J.G., Speck, S.H., Miller, G., Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein–Barr virus. J. Virol. 63 (1989), 1531–1539.
44. Rosa, M.D., Gottlieb, E., Lerner, M.R., Steitz, J.A., Striking similarities are exhibited by two small Epstein–Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol. Cell. Biol. 9 (1981), 785–796.
45. Ruf, I.K., Rhyne, P.W., Yang, H., Borza, C.M., Hutt-Fletcher, L.M., Cleveland, J.L., Sample, J.T., Epstein–Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Mol. Cell. Biol. 3 (1999), 1651–1660.
46. Ruf, I.K., Rhyne, P.W., Yang, C., Cleveland, J.L., Sample, J.T., Epstein–Barr virus small RNAs potentiate tumorigenicity of Burkitt's lymphoma cells independently of an effect on apoptosis. J. Virol. 74 (2000), 10223–10228.
47. Rymo, L., Identification of transcribed regions of Epstein–Barr virus DNA in Burkitt's lymphoma-derived cells. J. Virol. 32 (1979), 8–18.
48. Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T., Takada, K., EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25 (2006), 4207–4214.
49. Samanta, M., Iwakiri, D., Takada, K., Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 27 (2008), 4150–4160.
50. Schmidt, K.N., Leung, B., Kwong, M., Zarember, K.A., Satyal, S., Navas, T.A., Wang, F., Godowski, P.J., APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J. Immunol. 172 (2004), 138–143.
51. Schwemmle, M., Clemens, M.J., Hilse, K., Pfeifer, K., Tröster, H., Müller, W.E., Bachmann, M., Localization of Epstein–Barr virus-encoded RNAs EBER-1 anEBER-2 in interphase and mitotic Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 89 (1992), 10292–10296.
52. Sharp, T.V., Schwemmle, M., Jeffrey, I., Laing, K., Mellor, H., Proud, C.G., Hilse, K., Clemens, M.J., Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein–Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res. 21 (1993), 4483–4490.
53. Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., Takada, K., Isolation of Epstein–Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68 (1994), 6069–6073.
54. Sugawara, Y., Mizugaki, Y., Uchida, T., Torii, T., Imai, S., Makuuchi, M., Takada, K., Detection of Epstein–Barr virus (EBV) in hepatocellular carcinoma tissue: A novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 256 (1999), 196–202.
55. Swaminathan, S., Tomkinson, B., Kieff, E., Recombinant Epstein–Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. J. Virol. 66 (1991), 5133–5136.
56. Tabiasco, J., Devêvre, E., Rufer, N., Salaun, B., Cerottini, J.C., Speiser, D., Romero, D., Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J. Immunol. 177 (2006), 8708–8713.
57. Takada, K., Cross-linking of cell surface immunoglobulins induces Epstein–Barr virus in Burkitt's lymphoma lines. Int. J. Cancer 33 (1984), 27–32.
58. Takada, K., Epstein–Barr virus and gastric carcinoma. Mol. Pathol. 53 (2000), 255–261.
59. Takada, K., Ono, Y., Synchronous and sequential activation of latently infected Epstein–Barr virus genomes. J. Virol. 63 (1989), 445–449.
60. Takada, K., Horinouchi, K., Ono, Y., Aya, T., Osato, T., Takahashi, M., Hayasaka, S., An Epstein–Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes 2 (1991), 147–156.
61. Toczyski, D.P., Steitz, J.A., EAP, a highly conserved cellular protein associated with Epstein–Barr virus small RNAs (EBERs). EMBO J. 10 (1991), 459–466.
62. Toczyski, D.P., Steitz, J.A., The cellular RNA-binding protein EAP recognizes a conserved stem-loop in the Epstein–Barr virus small RNA EBER 1. Mol. Cell. Biol. 1 (1993), 703–710.
63. Toczyski, D.P., Matera, A.G., Ward, D.C., Steitz, J.A., The Epstein–Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc. Natl. Acad. Sci. USA 91 (1994), 3463–3467.
64. Vuyisich, M., Spanggord, R.J., Beal, P.A., The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein–Barr virus. EMBO Rep. 3 (2002), 622–627.
65. Wen, S., Shimizu, N., Yoshiyama, H., Mizugaki, Y., Shinozaki, F., Takada, K., Association of Epstein–Barr virus (EBV) with Sjögren's syndrome: Differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am. J. Pathol. 149 (1996), 1511–1517.
66. Wen, S., Mizugaki, Y., Shinozaki, F., Takada, K., Epstein–Barr virus (EBV) infection in salivary gland tumors: Lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells. Virology 227 (1997), 484–487.
67. Wu, Y., Maruo, S., Yajima, M., Kanda, T., Takada, K., Epstein–Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J. Virol. 80 (2007), 11236–11245.
68. Yajima, M., Kanda, T., Takada, K., Critical role of Epstein–Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J. Virol. 79 (2005), 4298–4307.
69. Yamamoto, N., Takizawa, T., Iwanaga, Y., Shimizu, N., Yamamoto, N., Malignant transformation of B lymphoma cell line BJAB by Epstein–Barr virus-encoded small RNAs. FEBS Lett. 484 (2000), 153–158.
70. Yang, L., Aozasa, K., Oshimi, K., Takada, K., Epstein–Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res. 64 (2004), 5332–5337.
71. Yao, Q.Y., Tierney, R.J., Croom-Carter, D., Cooper, G.M., Ellis, C.J., Rowe, M., Rickinson, A.B., Isolation of intertypic recombinants of Epstein–Barr virus from T-cell-immunocompromised individuals. J. Virol. 70 (1996), 4895–4903.
72. Yao, Y., Minter, H.A., Chen, X., Reynolds, G.M., Bromley, M., Arrand, J.R., Heterogeneity of HLA and EBER expression in Epstein–Barr virus-associated nasopharyngeal carcinoma. Int. J. Cancer 88 (2000), 949–955.
73. Yoneyama, M., Fujita, T., Function of RIG-I-like receptors in antiviral innate immunity. J. Biol. Chem. 282 (2007), 15315–15318.
74. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., Fujita, T., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004), 730–737.
75. Yoshiyama, H., Shimizu, N., Takada, K., Persistent Epstein–Barr virus infection in a human T-cell line: Unique program of latent virus expression. EMBO J. 14 (1995), 3706–3711.